{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:51:15Z","timestamp":1769025075486,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1053\/hupa.2003.6","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T18:13:53Z","timestamp":1046801633000},"page":"41-47","source":"Crossref","is-referenced-by-count":15,"title":["Cell cycle regulators in multiple myeloma: Prognostic implications of p53 nuclear accumulation"],"prefix":"10.1053","volume":"34","author":[{"given":"Giancarlo","family":"Pruneri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Carboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Intini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Colombi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Viale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Neri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/hupa.2003.6_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: Increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1053\/hupa.2003.6_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"El-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1053\/hupa.2003.6_bib3","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1101\/gad.7.7a.1126","article-title":"The p53-mdm-2 autoregulatory feedback loop","volume":"7","author":"Wu","year":"1993","journal-title":"Genes Dev"},{"key":"10.1053\/hupa.2003.6_bib4","first-page":"2539","article-title":"p53 and RAS gene mutations in multiple myeloma","volume":"7","author":"Portier","year":"1992","journal-title":"Oncogene"},{"key":"10.1053\/hupa.2003.6_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V81.1.128.128","article-title":"p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy","volume":"81","author":"Neri","year":"1993","journal-title":"Blood"},{"key":"10.1053\/hupa.2003.6_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0925-5710(95)00394-8","article-title":"N-ras and p53 gene mutations are very rare events in multiple myeloma","volume":"62","author":"Yasuga","year":"1995","journal-title":"Int J Hematol"},{"key":"10.1053\/hupa.2003.6_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/mp.50.1.18","article-title":"p53 gene mutations in multiple myeloma","volume":"50","author":"Owen","year":"1997","journal-title":"Mol Pathol"},{"key":"10.1053\/hupa.2003.6_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V92.3.802","article-title":"Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy","volume":"92","author":"Drach","year":"1998","journal-title":"Blood"},{"key":"10.1053\/hupa.2003.6_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2141.1997.3473161.x","article-title":"Cyclin D1 and p16INK4A are preferentially expressed in immature and mature myeloma cells, respectively","volume":"99","author":"Kawano","year":"1997","journal-title":"Brit J Haematol"},{"key":"10.1053\/hupa.2003.6_bib10","first-page":"3065","article-title":"Arsenic trioxide-mediated growth inhibition in MC\/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis","volume":"60","author":"Park","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/hupa.2003.6_bib11","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood.V90.5.1982","article-title":"MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells","volume":"90","author":"Teoh","year":"1997","journal-title":"Blood"},{"key":"10.1053\/hupa.2003.6_bib12","first-page":"642","article-title":"Expression of the cell-cycle\u2013related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: Correlation with cyclin D1 immunoreactivity","volume":"11","author":"Lai","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1053\/hupa.2003.6_bib13","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1053\/hupa.2003.6_bib14","first-page":"1211","article-title":"p27kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors","volume":"55","author":"Ponce-Castaneda","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/hupa.2003.6_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.neo.7900033","article-title":"p27KIP1 deletions in childhood acute lymphoblastic leukemia","volume":"1","author":"Komuro","year":"1999","journal-title":"Neoplasia"},{"key":"10.1053\/hupa.2003.6_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1096\/fasebj.13.8.773","article-title":"Cyclin E in human cancers","volume":"13","author":"Donnellan","year":"1999","journal-title":"FASEB J"},{"key":"10.1053\/hupa.2003.6_bib17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1182\/blood.V92.3.770","article-title":"Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas: Prognostic implications","volume":"92","author":"Erlanson","year":"1998","journal-title":"Blood"},{"key":"10.1053\/hupa.2003.6_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/sj.leu.2401640","article-title":"Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia","volume":"14","author":"Yokozawa","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/hupa.2003.6_bib19","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0002-9440(10)65022-5","article-title":"Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14)","volume":"156","author":"Pruneri","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2003.6_bib20","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1053\/hupa.2003.6_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ajcp\/87.3.342","article-title":"Histologic classification and staging of multiple myeloma: A retrospective and prospective study of 674 cases","volume":"87","author":"Bartl","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/hupa.2003.6_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0889-8588(05)70419-6","article-title":"Standard therapy versus autologous transplantation in multiple myeloma","volume":"11","author":"Attal","year":"1997","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/hupa.2003.6_bib23","first-page":"785","article-title":"MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: Association with wild-type p53 accumulation","volume":"10","author":"Pruneri","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1053\/hupa.2003.6_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)65558-7","article-title":"Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor","volume":"153","author":"Quintanilla-Martinez","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2003.6_bib25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood"},{"key":"10.1053\/hupa.2003.6_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35106009","article-title":"Assessing TP53 status in human tumours to evaluate clinical outcome","volume":"1","author":"Soussi","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/hupa.2003.6_bib27","first-page":"3391","article-title":"Induction of WAF1\/CIP1 by a p53-independent pathway","volume":"54","author":"Michieli","year":"1994","journal-title":"Cancer Res"},{"key":"10.1053\/hupa.2003.6_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/carcin\/23.4.541","article-title":"p53-Mdm2\u2014the affair that never ends","volume":"23","author":"Alarcon-Vargas","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1053\/hupa.2003.6_bib29","doi-asserted-by":"crossref","first-page":"15608","DOI":"10.1073\/pnas.95.26.15608","article-title":"Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis","volume":"95","author":"Jones","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/hupa.2003.6_bib30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","article-title":"The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation","volume":"69","author":"Momand","year":"1992","journal-title":"Cell"},{"key":"10.1053\/hupa.2003.6_bib31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/362857a0","article-title":"Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53","volume":"362","author":"Oliner","year":"1993","journal-title":"Nature"},{"key":"10.1053\/hupa.2003.6_bib32","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/nar\/26.15.3453","article-title":"The MDM2 gene amplification database","volume":"26","author":"Momand","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/hupa.2003.6_bib33","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood.V82.9.2617.2617","article-title":"The human MDM-2 oncogene is overexpressed in leukemias","volume":"82","author":"Bueso-Ramos","year":"1993","journal-title":"Blood"},{"key":"10.1053\/hupa.2003.6_bib34","first-page":"1291","article-title":"Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes","volume":"7","author":"Preudhomme","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/hupa.2003.6_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2141.1994.tb04754.x","article-title":"Lack of MDM2 amplification in human leukaemia","volume":"86","author":"Ridge","year":"1994","journal-title":"Brit J Haematol"},{"key":"10.1053\/hupa.2003.6_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00019606-199603000-00006","article-title":"mdm-2 oncogene expression in non-Hodgkin's lymphomas","volume":"5","author":"Kawamata","year":"1996","journal-title":"Diagn Mol Pathol"},{"key":"10.1053\/hupa.2003.6_bib37","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.onc.1201702","article-title":"Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells","volume":"16","author":"Capoulade","year":"1998","journal-title":"Oncogene"},{"key":"10.1053\/hupa.2003.6_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1073\/pnas.95.1.195","article-title":"Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage","volume":"95","author":"Chen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/hupa.2003.6_bib39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V97.4.1043","article-title":"Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides","volume":"97","author":"Capoulade","year":"2001","journal-title":"Blood"},{"key":"10.1053\/hupa.2003.6_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-5002(00)00160-4","article-title":"Expression of cyclin E and cyclin D1 in non-small cell lung cancers","volume":"31","author":"Yamanouchi","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1053\/hupa.2003.6_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/hupa.2001.21141","article-title":"Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications","volume":"32","author":"Donnellan","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1053\/hupa.2003.6_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S","article-title":"Multiple functions of p27kip1 and its alterations in tumor cells: A review","volume":"183","author":"Sgambato","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1053\/hupa.2003.6_bib43","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V82.4.1092.1092","article-title":"Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents","volume":"82","author":"Lotem","year":"1993","journal-title":"Blood"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817702297063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817702297063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T18:30:40Z","timestamp":1584469840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817702297063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0046817702297063"],"URL":"https:\/\/doi.org\/10.1053\/hupa.2003.6","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}